- Home
- INDO vs CCEL Comparison
INDO vs CCEL Comparison
Compare INDO & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INDO | CCEL |
|---|---|---|
| Founded | 2018 | 1989 |
| Country | Indonesia | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Managed Health Care |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.7M | 32.7M |
| IPO Year | 2019 | 1997 |
Fundamental Metrics
Financial Performance| Metric | INDO | CCEL |
|---|---|---|
| Price | $3.03 | $3.74 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 218.9K | 3.5K |
| Earning Date | 11-14-2025 | 10-15-2025 |
| Dividend Yield | N/A | ★ 10.53% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,293,625.00 | ★ $31,747,500.00 |
| Revenue This Year | N/A | $0.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.10 | $3.57 |
| 52 Week High | $7.95 | $8.79 |
Technical Indicators
Market Signals| Indicator | INDO | CCEL |
|---|---|---|
| Relative Strength Index (RSI) | 62.98 | 41.23 |
| Support Level | $2.80 | $3.81 |
| Resistance Level | $2.98 | $4.38 |
| Average True Range (ATR) | 0.14 | 0.26 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 95.82 | 20.99 |
Price Performance
Historical ComparisonAbout INDO Indonesia Energy Corporation Limited
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. The company is an independent energy company engaged in the oil and gas business and holds two oil and gas assets through its subsidiaries in Indonesia: The Kruh Block and the Citarum Block. It has also identified a potential third exploration block known as the Rangkas area. . Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.